238 related articles for article (PubMed ID: 22056948)
41. Clinical and pathologic correlates in surgical stage II endometrial carcinoma.
Cohn DE; Woeste EM; Cacchio S; Zanagnolo VL; Havrilesky LJ; Mariani A; Podratz KC; Huh WK; Whitworth JM; McMeekin DS; Powell MA; Boyd E; Phillips GS; Fowler JM
Obstet Gynecol; 2007 May; 109(5):1062-7. PubMed ID: 17470583
[TBL] [Abstract][Full Text] [Related]
42. Comparison of D&C and hysterectomy pathologic findings in endometrial cancer patients.
Wang X; Huang Z; Di W; Lin Q
Arch Gynecol Obstet; 2005 Jul; 272(2):136-41. PubMed ID: 15666177
[TBL] [Abstract][Full Text] [Related]
43. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
44. Preoperative and postoperative correlation of histopathological findings in cases of endometrial hyperplasia.
Gundem G; Sendag F; Kazandi M; Akercan F; Mgoyi L; Terek MC; Zekioglu O
Eur J Gynaecol Oncol; 2003; 24(3-4):330-3. PubMed ID: 12807251
[TBL] [Abstract][Full Text] [Related]
45. High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy.
Sonoda Y; Zerbe M; Smith A; Lin O; Barakat RR; Hoskins WJ
Gynecol Oncol; 2001 Mar; 80(3):378-82. PubMed ID: 11263935
[TBL] [Abstract][Full Text] [Related]
46. [An analysis on the clinicopathological characteristics of 79 cases atypical endometrial hyperplasia].
Wang ZQ; Yang XQ; Wang JL; Xie JL; Shen DH; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):19-23. PubMed ID: 21429429
[TBL] [Abstract][Full Text] [Related]
47. [Accuracy of preoperative tumor grading and intraoperative gross examination of myometrial invasion in clinical stage I endometriod adenocarcinoma].
Wang XY; Pan ZM; Xie X
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):518-21. PubMed ID: 19957552
[TBL] [Abstract][Full Text] [Related]
48. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics.
McKenney JK; Longacre TA
Adv Anat Pathol; 2009 Jan; 16(1):1-22. PubMed ID: 19098463
[TBL] [Abstract][Full Text] [Related]
49. Concurrent endometrial carcinoma in patients with a curettage diagnosis of endometrial hyperplasia.
Chen YL; Cheng WF; Lin MC; Huang CY; Hsieh CY; Chen CA
J Formos Med Assoc; 2009 Jun; 108(6):502-7. PubMed ID: 19515631
[TBL] [Abstract][Full Text] [Related]
50. Molecular analysis of endometrial hyperplasia in HNPCC-suspicious patients may predict progression to endometrial carcinoma.
Sutter C; Dallenbach-Hellweg G; Schmidt D; Baehring J; Bielau S; von Knebel Doeberitz M; Gebert J
Int J Gynecol Pathol; 2004 Jan; 23(1):18-25. PubMed ID: 14668545
[TBL] [Abstract][Full Text] [Related]
51. Patients with atypical hyperplasia of the endometrium should be treated in oncological centers.
Antonsen SL; Ulrich L; Høgdall C
Gynecol Oncol; 2012 Apr; 125(1):124-8. PubMed ID: 22198048
[TBL] [Abstract][Full Text] [Related]
52. Factors predictive of endometrial carcinoma in patients with atypical endometrial hyperplasia on preoperative histology.
Touboul C; Piel B; Koskas M; Gonthier C; Ballester M; Cortez A; Daraï E
Anticancer Res; 2014 Oct; 34(10):5671-6. PubMed ID: 25275072
[TBL] [Abstract][Full Text] [Related]
53. Diagnosis and follow-up of atypical hyperplasia of corpus endometrium--a critical methodological investigation.
Geppert M; Smyczek-Gargya B; Menton M
Zentralbl Gynakol; 1993; 115(11):492-4. PubMed ID: 8296494
[TBL] [Abstract][Full Text] [Related]
54. Potential benefit of lymphadenectomy for the treatment of node-negative locally advanced uterine cancers.
Seago DP; Raman A; Lele S
Gynecol Oncol; 2001 Nov; 83(2):282-5. PubMed ID: 11606085
[TBL] [Abstract][Full Text] [Related]
55. New challenges in detecting, grading, and staging endometrial cancer after uterine morcellation.
Rivard C; Salhadar A; Kenton K
J Minim Invasive Gynecol; 2012; 19(3):313-6. PubMed ID: 22417903
[TBL] [Abstract][Full Text] [Related]
56. Clinical significance of a cytologic diagnosis of atypical glandular cells of undetermined significance.
Cheng RF; Hernandez E; Anderson LL; Heller PB; Shank R
J Reprod Med; 1999 Nov; 44(11):922-8. PubMed ID: 10589401
[TBL] [Abstract][Full Text] [Related]
57. Uterine body cancer mass screening at Tokai University Hospital.
Nagase E; Yasuda M; Kajiwara H; Osamura RY; Yoshitake T; Hirasawa T; Muramatsu T; Miyamoto T; Murakami M; Makino T; Ogawa T
Tokai J Exp Clin Med; 2004 Jun; 29(2):43-8. PubMed ID: 15473339
[TBL] [Abstract][Full Text] [Related]
58. Coexisting ovarian malignancy in young women with endometrial cancer.
Walsh C; Holschneider C; Hoang Y; Tieu K; Karlan B; Cass I
Obstet Gynecol; 2005 Oct; 106(4):693-9. PubMed ID: 16199623
[TBL] [Abstract][Full Text] [Related]
59. Spontaneous endometrial hyperplasia. A prospective, 5 year follow-up of 246 patients after abrasio only, including 380 patients followed-up for 2 years.
Lindahl B; Willén R
Anticancer Res; 1994; 14(5B):2141-6. PubMed ID: 7840513
[TBL] [Abstract][Full Text] [Related]
60. [Difficulties and mistakes in the diagnosis of atypical endometrial hyperplasia].
Kxmel'nitskaia NM; Neĭshtadt EL; Khalimdzhanov ZK
Arkh Patol; 2006; 68(6):39-42. PubMed ID: 17290894
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]